Ingevity (NGVT) Projected to Post Quarterly Earnings on Wednesday

Ingevity (NYSE:NGVTGet Free Report) will likely be issuing its Q3 2025 results after the market closes on Wednesday, November 5th. Analysts expect the company to announce earnings of $1.14 per share and revenue of $360.4330 million for the quarter. Interested persons may review the information on the company’s upcoming Q3 2025 earningreport for the latest details on the call scheduled for Thursday, November 6, 2025 at 10:00 AM ET.

Ingevity (NYSE:NGVTGet Free Report) last released its quarterly earnings results on Friday, March 24th. The company reported $0.78 earnings per share for the quarter. Ingevity had a negative net margin of 16.35% and a positive return on equity of 84.92%. The company had revenue of $336.00 million during the quarter. On average, analysts expect Ingevity to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Ingevity Stock Up 0.1%

NYSE NGVT opened at $53.79 on Tuesday. The company has a current ratio of 1.36, a quick ratio of 0.80 and a debt-to-equity ratio of 10.24. Ingevity has a 1-year low of $28.49 and a 1-year high of $60.77. The company has a 50 day moving average of $56.14 and a 200-day moving average of $48.07. The company has a market cap of $1.96 billion, a price-to-earnings ratio of -9.04 and a beta of 1.40.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on NGVT. BMO Capital Markets lifted their price target on shares of Ingevity from $62.00 to $68.00 and gave the company an “outperform” rating in a research report on Friday, September 5th. Wall Street Zen upgraded shares of Ingevity from a “buy” rating to a “strong-buy” rating in a research report on Saturday, August 9th. Wells Fargo & Company lifted their price target on shares of Ingevity from $38.00 to $48.00 and gave the company an “equal weight” rating in a research report on Monday, July 14th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Ingevity in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $58.00.

Get Our Latest Stock Analysis on Ingevity

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the company. Simcoe Capital Management LLC increased its stake in Ingevity by 188.8% in the second quarter. Simcoe Capital Management LLC now owns 624,935 shares of the company’s stock valued at $26,928,000 after acquiring an additional 408,508 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in Ingevity by 311.8% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 600,380 shares of the company’s stock valued at $23,769,000 after acquiring an additional 454,579 shares during the last quarter. Bank of America Corp DE increased its stake in Ingevity by 16.5% in the second quarter. Bank of America Corp DE now owns 278,212 shares of the company’s stock valued at $11,988,000 after acquiring an additional 39,323 shares during the last quarter. Ameriprise Financial Inc. increased its stake in Ingevity by 0.4% in the second quarter. Ameriprise Financial Inc. now owns 207,438 shares of the company’s stock valued at $8,939,000 after acquiring an additional 764 shares during the last quarter. Finally, Public Sector Pension Investment Board increased its stake in Ingevity by 7.9% in the second quarter. Public Sector Pension Investment Board now owns 124,346 shares of the company’s stock valued at $5,358,000 after acquiring an additional 9,108 shares during the last quarter. 91.59% of the stock is owned by institutional investors.

Ingevity Company Profile

(Get Free Report)

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.

Featured Stories

Earnings History for Ingevity (NYSE:NGVT)

Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.